Developer docs
API playgroundTry for free, no card

Search company profiles

Limbic

Full company profile

uuid0000e3v

Namestring
Limbic
Legal namestring
Limbic Limited
Websiteurl
limbic.ai
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Limbic is a clinical AI company that builds software for mental healthcare providers, headquartered in London with a US regional office in New York. Its product portfolio centers on two complementary offerings: Limbic Access, a web-based conversational AI for patient self-referral, eligibility checking, and diagnostic triage (the first AI mental health chatbot globally to achieve Class IIa UKCA medical device certification); and Limbic Care, a generative AI companion mobile app that delivers CBT between clinical sessions. Both products are powered by the Limbic Layer, a proprietary AI architecture that sits between users and large language models to enforce clinical safety, validity, and regulatory compliance on every interaction. Supporting tools include a Therapist Portal and Admin Portal for clinician workflow integration, plus a TORTUS-powered AI Scribe for automated clinical documentation added in June 2026.

The company sells exclusively through enterprise B2B SaaS contracts to NHS Talking Therapies services in the UK (45 trusts covering 45% of NHS England regions, with named customers including Everyturn, Living Well Consortium, NHS Bradford and Craven, Essex Partnership, Surrey and Borders, and Greater Manchester Resilience Hub) and, more recently, to US health plans, health systems, and behavioral health providers (Rogers Behavioral Health is the anchor US reference customer). Pricing is not publicly disclosed and is negotiated via multi-year software license agreements through a sales-led enterprise motion with "Book a demo" and "Talk to sales" CTAs. The company was founded in 2020 by a team of 10 PhDs, is privately held and venture-backed (Series A of $14M led by Khosla Ventures in March 2024), and has secured extensive regulatory and quality certifications including Class IIa UKCA, ISO 13485, ISO 14971, ISO 27001, Cyber Essentials, HIPAA, and GDPR compliance.

Short descriptiontext

Limbic is a clinical AI company that builds Class IIa-certified software for mental healthcare providers, offering AI-powered patient intake (Limbic Access) and generative AI therapy support (Limbic Care) to NHS Talking Therapies services, US health plans, and behavioral health providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mental health AI software, clinical decision support, behavioral health SaaS, patient intake automation, digital therapeutics platform
Industry2 codes
1Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
CodeHLALAFAFPrimaryYes
2Psychiatry & Medication Management Platforms
CodeHLALAEABPrimaryNo
NAICS code1 code
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Mental Health Clinical AI Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software License & Subscription (B2B SaaS)
TypeSubscription Recurring
Description

Limbic operates as a B2B SaaS company, licensing its clinical AI software to healthcare providers including NHS trusts, behavioral health providers, health plans, and health systems. Fees are set out in separate software license agreements between Limbic and its customers. The company reserves the right to charge fees for the Software and Services as outlined in the Agreement.

limbic.ai
2U.S. Market Expansion
TypeSubscription Recurring
Description

Following $14M funding led by Khosla Ventures, Limbic plans to expand its mental health AI services to U.S. health providers, targeting health plans and health systems in the United States as a new revenue stream.

finsmes.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise B2B licensing - pricing not publicly disclosed
ModelSubscriptionBilling cadenceMulti-year contract
Notes

The company reserves the right to charge for the Software and Services and such fees and charges shall be set out in a separate agreement. No public pricing is available.

limbic.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Limbic Access
Description

Clinical AI assistant for patient intakes and assessments. A chatbot that handles self-referral, eligibility checking, and triage for mental health services. Class IIa UKCA certified medical device.

limbic.ai
+2 more records
Core offering1 text field

Limbic builds clinical AI software for mental healthcare providers, delivered as a B2B SaaS platform. Its two commercial products, Limbic Access (a patient intake and triage chatbot) and Limbic Care (a generative AI therapy companion mobile app), are powered by The Limbic Layer, a proprietary clinical safety layer that mediates between users and large language models. Customers include NHS Talking Therapies services, U.S. health plans, behavioral health providers, and health systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 13 values shown
  • 2x patient recovery rates
+12 more records
Product overview1 text field

Limbic offers a unified clinical AI platform for mental healthcare with two primary products: Limbic Access (web chatbot for patient intake and assessment with 93% diagnostic accuracy and Class IIa UKCA medical device certification) and Limbic Care (mobile app generative AI companion for ongoing patient engagement with therapy support and AI-powered clinical documentation). Both products are powered by The Limbic Layer, a proprietary AI that sits between users and LLMs to ensure clinical safety and precision. Clinician-facing tools include the Therapist Portal and Admin Portal for managing patient data and care delivery. The company serves health plans, behavioral health providers, health systems, and NHS Talking Therapies services.

Product and service5 records
1Limbic Access
CategoryPatient Intake & Triage AI
Description

Clinical AI assistant for patient intakes and assessments, delivered as a web chatbot for healthcare providers. Performs AI-powered self-referral and e-triage with 93% diagnostic accuracy for 8 common mental health disorders, and is the first AI mental health chatbot with Class IIa UKCA medical device certification.

2Limbic Care
CategoryDigital Therapy Companion
Description

Generative AI care companion mobile app for on-demand patient support between therapy sessions. Delivers CBT through conversational chat, guides patients through interactive CBT exercises, and is available to clinicians' caseloads for patient engagement.

3The Limbic Layer
CategoryClinical AI Safety Platform
Description

Proprietary clinical AI platform that sits between users (patients and clinicians) and large language models to ensure safety, clinical precision, and regulatory compliance in every interaction. Processes user inputs through clinical best practices and screens LLM responses for safety and clinical validity.

4Limbic Therapist Portal
CategoryClinician Dashboard
Description

Clinician-facing web application that consolidates patient information collected via Limbic Access and Limbic Care. Provides pre-assessment data including life circumstances, presenting problems, likely diagnoses, and risk levels to support clinical decision-making.

5Limbic Admin Portal
CategoryAdministrative Management Software
Description

Web-based administrative application for management of Limbic services across a healthcare provider organization, complementing the Therapist Portal in the clinician-facing software suite.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-04
Description

Limbic partnered with TORTUS to embed a Class I Medical Device ambient voice technology (AI scribe) into Limbic Care. The partnership combines TORTUS's automated clinical documentation with Limbic's mental health AI platform, providing NHS mental health services with AI-assisted consultation documentation. TORTUS's AVT is a Class I Medical Device aligned with Limbic's safety and governance framework.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-11-01
Description

Limbic and PCMIS announced an integration partnership, enabling seamless interoperability between Limbic Access and PCMIS's patient management system. This integration supports NHS Talking Therapies services in streamlining their digital workflows and improving clinical efficiency. The partnership was co-marketed through joint webinars.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-11-01
Description

Everyturn Mental Health partnered with Limbic in November 2021 to support digital transformation across its nine NHS Talking Therapies services. The partnership included deep integration with Everyturn's in-house Salesforce-based service management platform (Insight+), resulting in 32% referral increase, 38% of referrals outside working hours, and 33% identified for accelerated assessment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The NHS Confederation hosted a webinar in partnership with Limbic to launch a briefing aimed at helping mental health trusts demystify AI adoption, explore policy developments, and address governance concerns. Limbic's AI tools are used by over 500,000 patients across 45% of NHS England regions, and this partnership aims to expand safe clinical AI implementation across the NHS.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI-powered mental health chatbot delivering CBT and emotional support. Direct competitor with similar digital therapeutic approach for mental health conditions, though Woebot has historically targeted D2C and B2B2C channels.

TypeDirect peer
Description

AI mental health chatbot offering CBT, psychoeducation, and emotional support. Direct peer serving both employer/insurer and direct consumer mental health markets with similar conversational AI therapy approach.

TypeDirect peer
Description

Mental health benefits platform serving employers and health plans with AI-enabled care navigation, therapy matching, and digital CBT. Comparable in selling to US health plans with AI-augmented mental health care delivery.

TypeDirect peer
Description

Mental health benefits platform for employers with AI-enabled therapy matching and digital care options. Direct competitor in the US employer/health plan market with substantial capital and similar B2B2C motion.

TypeDirect peer
Description

Digital mental health platform combining therapy and medication management with online assessments. Comparable B2B mental health platform model targeting similar provider and payer segments.

TypeBroad incumbent
Description

Larger mental health platform combining consumer wellness content (Headspace) with therapy services (Ginger). Broader incumbent offering content plus human therapy plus AI tools across employer and consumer segments.

TypeDirect peer
Description

Online therapy platform with AI-enhanced matching and asynchronous messaging. Sells B2B to health plans and employers with similar AI-augmented mental health service delivery model.

TypeBroad incumbent
Description

Largest online therapy platform (Teladoc-owned) offering human therapy with some AI tools. Incumbent with massive scale in B2C and emerging B2B2C mental health, broader portfolio than Limbic's clinical AI focus.

TypeDirect peer
Description

Digital therapeutics company with FDA-cleared products for insomnia (Sleepio) and anxiety (Daylight). Direct peer in digital therapeutics for mental health with regulatory clearance and similar enterprise sales motion.

TypeEmerging player
Description

AI voice biomarker detection for mental health assessment. Emerging player using AI for mental health screening with similar AI-first approach, though focused on voice biomarkers rather than conversational therapy.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Limbic

Mental Health Clinical AI Softwarelimbic.ai

Limbic is a clinical AI company that builds Class IIa-certified software for mental healthcare providers, offering AI-powered patient intake (Limbic Access) and generative AI therapy support (Limbic Care) to NHS Talking Therapies services, US health plans, and behavioral health providers.

What Limbic does

Limbic is a clinical AI company that builds software for mental healthcare providers, headquartered in London with a US regional office in New York. Its product portfolio centers on two complementary offerings: Limbic Access, a web-based conversational AI for patient self-referral, eligibility checking, and diagnostic triage (the first AI mental health chatbot globally to achieve Class IIa UKCA medical device certification); and Limbic Care, a generative AI companion mobile app that delivers CBT between clinical sessions. Both products are powered by the Limbic Layer, a proprietary AI architecture that sits between users and large language models to enforce clinical safety, validity, and regulatory compliance on every interaction. Supporting tools include a Therapist Portal and Admin Portal for clinician workflow integration, plus a TORTUS-powered AI Scribe for automated clinical documentation added in June 2026.

The company sells exclusively through enterprise B2B SaaS contracts to NHS Talking Therapies services in the UK (45 trusts covering 45% of NHS England regions, with named customers including Everyturn, Living Well Consortium, NHS Bradford and Craven, Essex Partnership, Surrey and Borders, and Greater Manchester Resilience Hub) and, more recently, to US health plans, health systems, and behavioral health providers (Rogers Behavioral Health is the anchor US reference customer). Pricing is not publicly disclosed and is negotiated via multi-year software license agreements through a sales-led enterprise motion with "Book a demo" and "Talk to sales" CTAs. The company was founded in 2020 by a team of 10 PhDs, is privately held and venture-backed (Series A of $14M led by Khosla Ventures in March 2024), and has secured extensive regulatory and quality certifications including Class IIa UKCA, ISO 13485, ISO 14971, ISO 27001, Cyber Essentials, HIPAA, and GDPR compliance.

Limbic firmographics

Firmographics
Name
Limbic
Legal name
Limbic Limited
Website
https://limbic.ai
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Limbic is a clinical AI company that builds Class IIa-certified software for mental healthcare providers, offering AI-powered patient intake (Limbic Access) and generative AI therapy support (Limbic Care) to NHS Talking Therapies services, US health plans, and behavioral health providers.
Ownership category
akta.pro rank

Limbic industry classification

Industry
Product category
Mental Health Clinical AI Software
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro primary industry
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
akta.pro secondary industry
Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

  • Mental health AI software
  • Clinical decision support
  • Behavioral health SaaS
  • Patient intake automation
  • Digital therapeutics platform

Where Limbic is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Limbic business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software License & Subscription (B2B SaaS): Limbic operates as a B2B SaaS company, licensing its clinical AI software to healthcare providers including NHS trusts, behavioral health providers, health plans, and health systems. Fees are set out in separate software license agreements between Limbic and its customers. The company reserves the right to charge fees for the Software and Services as outlined in the Agreement.
  2. U.S. Market Expansion: Following $14M funding led by Khosla Ventures, Limbic plans to expand its mental health AI services to U.S. health providers, targeting health plans and health systems in the United States as a new revenue stream.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise B2B licensing - pricing not publicly disclosed

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Limbic product offering

Product offering

Core offering

Limbic builds clinical AI software for mental healthcare providers, delivered as a B2B SaaS platform. Its two commercial products, Limbic Access (a patient intake and triage chatbot) and Limbic Care (a generative AI therapy companion mobile app), are powered by The Limbic Layer, a proprietary clinical safety layer that mediates between users and large language models. Customers include NHS Talking Therapies services, U.S. health plans, behavioral health providers, and health systems.

Product overview

Limbic offers a unified clinical AI platform for mental healthcare with two primary products: Limbic Access (web chatbot for patient intake and assessment with 93% diagnostic accuracy and Class IIa UKCA medical device certification) and Limbic Care (mobile app generative AI companion for ongoing patient engagement with therapy support and AI-powered clinical documentation). Both products are powered by The Limbic Layer, a proprietary AI that sits between users and LLMs to ensure clinical safety and precision. Clinician-facing tools include the Therapist Portal and Admin Portal for managing patient data and care delivery. The company serves health plans, behavioral health providers, health systems, and NHS Talking Therapies services.

Differentiator

Problem solved

Functional benefit

Brands

  • Limbic Access: Clinical AI assistant for patient intakes and assessments. A chatbot that handles self-referral, eligibility checking, and triage for mental health services. Class IIa UKCA certified medical device.
  • Limbic Care
  • The Limbic Layer

Products and services

  • Limbic Access Clinical AI assistant for patient intakes and assessments, delivered as a web chatbot for healthcare providers. Performs AI-powered self-referral and e-triage with 93% diagnostic accuracy for 8 common mental health disorders, and is the first AI mental health chatbot with Class IIa UKCA medical device certification.
  • Limbic Care Generative AI care companion mobile app for on-demand patient support between therapy sessions. Delivers CBT through conversational chat, guides patients through interactive CBT exercises, and is available to clinicians' caseloads for patient engagement.
  • The Limbic Layer Proprietary clinical AI platform that sits between users (patients and clinicians) and large language models to ensure safety, clinical precision, and regulatory compliance in every interaction. Processes user inputs through clinical best practices and screens LLM responses for safety and clinical validity.
  • Limbic Therapist Portal Clinician-facing web application that consolidates patient information collected via Limbic Access and Limbic Care. Provides pre-assessment data including life circumstances, presenting problems, likely diagnoses, and risk levels to support clinical decision-making.
  • Limbic Admin Portal Web-based administrative application for management of Limbic services across a healthcare provider organization, complementing the Therapist Portal in the clinician-facing software suite.

Quantifiable outcome

  • 2x patient recovery rates
  • +12 more outcomes

Companies that use Limbic

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Limbic technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature9 records

Limbic partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and flagship.

  • TORTUScoreTechnology or Integration · 4 June 2026Limbic partnered with TORTUS to embed a Class I Medical Device ambient voice technology (AI scribe) into Limbic Care. The partnership combines TORTUS's automated clinical documentation with Limbic's mental health AI platform, providing NHS mental health services with AI-assisted consultation documentation. TORTUS's AVT is a Class I Medical Device aligned with Limbic's safety and governance framework.
  • PCMIScoreTechnology or Integration · 1 November 2021Limbic and PCMIS announced an integration partnership, enabling seamless interoperability between Limbic Access and PCMIS's patient management system. This integration supports NHS Talking Therapies services in streamlining their digital workflows and improving clinical efficiency. The partnership was co-marketed through joint webinars.
  • Everyturn Mental HealthflagshipStrategic or Co-development Partner · 1 November 2021Everyturn Mental Health partnered with Limbic in November 2021 to support digital transformation across its nine NHS Talking Therapies services. The partnership included deep integration with Everyturn's in-house Salesforce-based service management platform (Insight+), resulting in 32% referral increase, 38% of referrals outside working hours, and 33% identified for accelerated assessment.
  • NHS ConfederationcoreStrategic or Co-development PartnerThe NHS Confederation hosted a webinar in partnership with Limbic to launch a briefing aimed at helping mental health trusts demystify AI adoption, explore policy developments, and address governance concerns. Limbic's AI tools are used by over 500,000 patients across 45% of NHS England regions, and this partnership aims to expand safe clinical AI implementation across the NHS.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Limbic competitors and assessment

Company assessment

Direct peers

  • Woebot Health: AI-powered mental health chatbot delivering CBT and emotional support. Direct competitor with similar digital therapeutic approach for mental health conditions, though Woebot has historically targeted D2C and B2B2C channels.
  • Wysa: AI mental health chatbot offering CBT, psychoeducation, and emotional support. Direct peer serving both employer/insurer and direct consumer mental health markets with similar conversational AI therapy approach.
  • Spring Health: Mental health benefits platform serving employers and health plans with AI-enabled care navigation, therapy matching, and digital CBT. Comparable in selling to US health plans with AI-augmented mental health care delivery.
  • Lyra Health: Mental health benefits platform for employers with AI-enabled therapy matching and digital care options. Direct competitor in the US employer/health plan market with substantial capital and similar B2B2C motion.
  • Cerebral: Digital mental health platform combining therapy and medication management with online assessments. Comparable B2B mental health platform model targeting similar provider and payer segments.
  • Talkspace: Online therapy platform with AI-enhanced matching and asynchronous messaging. Sells B2B to health plans and employers with similar AI-augmented mental health service delivery model.
  • Big Health: Digital therapeutics company with FDA-cleared products for insomnia (Sleepio) and anxiety (Daylight). Direct peer in digital therapeutics for mental health with regulatory clearance and similar enterprise sales motion.

Broad incumbents

  • Headspace Health: Larger mental health platform combining consumer wellness content (Headspace) with therapy services (Ginger). Broader incumbent offering content plus human therapy plus AI tools across employer and consumer segments.
  • BetterHelp: Largest online therapy platform (Teladoc-owned) offering human therapy with some AI tools. Incumbent with massive scale in B2C and emerging B2B2C mental health, broader portfolio than Limbic's clinical AI focus.

Emerging players

  • Kintsugi: AI voice biomarker detection for mental health assessment. Emerging player using AI for mental health screening with similar AI-first approach, though focused on voice biomarkers rather than conversational therapy.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Limbic social profiles

Digital presence

Limbic compliance and trust

Trust signal

Compliance8 records

Limbic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Limbic leadership team

Management profile

Number of profiles

Profiles9 records

Limbic funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Limbic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Limbic

What does Limbic do?

Limbic builds clinical AI software for mental healthcare providers, delivered as a B2B SaaS platform. Its two commercial products, Limbic Access (a patient intake and triage chatbot) and Limbic Care (a generative AI therapy companion mobile app), are powered by The Limbic Layer, a proprietary clinical safety layer that mediates between users and large language models. Customers include NHS Talking Therapies services, U.S. health plans, behavioral health providers, and health systems.

Is Limbic a public or private company?

Limbic is a private company. It is classified as venture growth investor backed and is currently operating.

When was Limbic founded?

Limbic was founded in 2020. It employs 11 to 50 people.

Where is Limbic based?

Limbic is headquartered in London, United Kingdom, in the Europe region.

How does Limbic make money?

Two revenue lines are on record. Software License & Subscription (B2B SaaS) is the primary driver. The others are U.S. Market Expansion.

Who are Limbic's main competitors?

Direct peers on record are Woebot Health, Wysa, Spring Health, Lyra Health, Cerebral, Talkspace and Big Health. Broad incumbents are Headspace Health and BetterHelp. Kintsugi is listed as an emerging player.

Does Limbic have an API?

No public API is recorded for Limbic.

What industry is Limbic in?

Limbic's product category is Mental Health Clinical AI Software. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621420 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Beckershospitalreview4 companies sign on to FDA’s digital device pilotThe FDA selected four companies for its TEMPO pilot program for digital health devices tied to chronic disease care. SonderMind, Limbic, Cadence Solutions, and Dexcom are among the participants, with devices using generative AI. The FDA plans to select up to 40 participants across four clinical use areas.STATFDA pilot offers generative AI medical devices a path to patients before they are authorizedThe FDA's TEMPO pilot program accepted four generative AI medical devices, including products from Cadence and Limbic, allowing them to launch without marketing authorization. The pilot aims to expand technology options for the Medicare ACCESS model and test AI regulation in practice.FierceHealthcareLimbic selected to FDA pilot, will test voice AI therapy with Medicare enrolleesThe FDA has selected Limbic, maker of an AI-led behavioral health tool, as an early participant in its TEMPO pilot, which lets devices not yet cleared join the CMS ACCESS chronic care model. Limbic's voice AI agent, Unpacked, delivers 20-minute CBT sessions over phone calls to 34 million Medicare enrollees, waiving copays. The company submitted over 100 pages of documentation, including nine peer-reviewed studies.Endpoints NewsTry first, evaluate later: How the FDA is approaching digital health devicesThe FDA is quietly selecting participants for its TEMPO pilot program, which tests digital health device approaches. A third participant, behavioral health company Limbic, was added to the pilot's webpage. The article does not disclose the other participants, the pilot's timeline, or the evaluation criteria.Business Wire BlogLimbic Becomes First AI-Led Mental Healthcare Company Selected for FDA TEMPOLimbic has been selected by the U.S. Food and Drug Administration as the first AI-led mental healthcare company for its Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot program. The company will launch 'Unpacked,' a clinician-supervised AI cognitive behavioral therapy service for Medicare beneficiaries with depression and anxiety, starting August 27, 2026. This initiative aims to address the shortage of mental health professionals by providing scalable care while gathering real-world data for regulatory evaluation.HcinnovationgroupLimbic Becomes First AI-Led Mental Healthcare Company Selected for FDA TEMPOThe U.S. Food and Drug Administration (FDA) has selected London-based Limbic as the first AI-led mental healthcare provider for its new Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot, launching on August 27. The program will provide clinician-supervised AI therapy via telephone to Medicare patients with depression and anxiety while gathering real-world data on safety and outcomes. This initiative runs alongside CMS's ACCESS model, which reimburses providers based on patient improvement rather than service volume.Business Wire BlogNature Medicine Study Shows AI Outperforms Therapists on Cognitive Behavioral TherapyLimbic announced publication of a randomized, double-blind study in Nature Medicine showing its clinical reasoning AI system enables therapy agents to deliver cognitive behavioral therapy at levels rated superior to human therapists and standalone large language models. The study with 227 participants found that AI agents with Limbic's clinical reasoning layer scored 43% higher than standalone LLMs on the Cognitive Therapy Rating Scale, with 74.3% of AI-powered sessions exceeding the top 10% of human therapy sessions. A complementary real-world analysis of 19,674 therapy transcripts showed users with highest exposure to the Limbic Layer achieved a 51.7% recovery rate versus 32.8% among those with lower exposure.Health Service JournalHSJ Digital Awards 2023: Improving Mental Health Through DigitalThe article reports on the HSJ Digital Awards 2023, recognizing initiatives that improve mental health through digital solutions. Notable winners include Limbic and Mind Matters, along with several projects across UK healthcare organizations that use digital tools like AI chatbots and virtual reality.Health Service JournalHSJ Partnership Awards 2023: Best Mental Health Partnership with the NHSLimbic and Surrey and Borders Partnership FT won the 2023 HSJ Partnership Award for their AI chatbot designed to improve access to mental health support, efficiency, and patient experience within the NHS. The chatbot, which is spreading to 25% of trusts, demonstrably saves clinician time and has shown financial benefits, possibly expanding access to hard-to-reach groups.NhsconfedDemystifying AI in Mental Health ServicesThe NHS Confederation is hosting a webinar in partnership with Limbic to launch a briefing aimed at helping mental health trusts demystify AI adoption, explore policy developments, and address governance concerns. Limbic's AI tools are currently used by over 500,000 patients across 45% of NHS England regions, with the company working to expand safe clinical AI implementation. The briefing will cover use cases, key implementation pillars, and practical concerns around liability and governance in mental healthcare settings.